The results indicated a decrease in tumor size, growth rate, GLI2 messenger RNA, and protein expression, indicating that GLI2ASO may serve as a specific treatment for BLCA with promise for advancement (Raven et al., 2019). This evidence concerns the gene GLI2 and neoplasm.